{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:05:41Z","timestamp":1792663541326,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022426","name":"National Indian Health Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218354","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:08:13Z","timestamp":1771891693000},"page":"218354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mitochondrial reverse electron transport regulates glioma stemness through Sirt3-HIF1\u03b1-SOX2 signaling"],"prefix":"10.1016","volume":"645","author":[{"given":"Tejinder Pal","family":"Khaket","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Rimal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Chavda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41467-019-09853-z","article-title":"Stem cell-associated heterogeneity in glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment","volume":"10","author":"Dirkse","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13287-025-04352-z","article-title":"Glioma stem cells: drivers of tumor progression and recurrence","volume":"16","author":"He","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.canlet.2026.218354_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.582694","article-title":"Mitochondria's role in the maintenance of cancer stem cells in glioblastoma","volume":"11","author":"Iranmanesh","year":"2021","journal-title":"Front. Oncol."},{"issue":"18","key":"10.1016\/j.canlet.2026.218354_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17183062","article-title":"Targeting the mitochondria in high-grade gliomas","volume":"17","author":"Sathe","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.canlet.2026.218354_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.devcel.2021.12.020","article-title":"Regulation of reverse electron transfer at mitochondrial complex I by unconventional notch action in cancer stem cells","volume":"57","author":"Ojha","year":"2022","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.canlet.2026.218354_bib7","article-title":"Deregulation of mitochondrial reverse electron transport alters the metabolism of reactive oxygen species and NAD+\/NADH and presents a therapeutic target in alzheimer's disease","volume":"4","author":"Rimal","year":"2024","journal-title":"Ageing Neur Dis."},{"issue":"4","key":"10.1016\/j.canlet.2026.218354_bib8","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202255548","article-title":"Reverse electron transfer is activated during aging and contributes to aging and age-related disease","volume":"24","author":"Rimal","year":"2023","journal-title":"EMBO Rep."},{"issue":"9","key":"10.1016\/j.canlet.2026.218354_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biology14091140","article-title":"Mitochondrial reverse electron transport: mechanisms, pathophysiological roles, and therapeutic potential","volume":"14","author":"Bao","year":"2025","journal-title":"Biology"},{"issue":"5","key":"10.1016\/j.canlet.2026.218354_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biom15050614","article-title":"Targeting the electron transport system for enhanced longevity","volume":"15","author":"Radovic","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218354_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103047","article-title":"Reactive oxygen species generation by reverse electron transfer at mitochondrial complex I under simulated early reperfusion conditions","volume":"70","author":"Tabata Fukushima","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218354_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fonc.2016.00222","article-title":"Targeting SOX2 as a therapeutic strategy in glioblastoma","volume":"6","author":"Garros-Regulez","year":"2016","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218354_bib13","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.32604\/or.2025.070031","article-title":"RNA expression signatures in glioblastoma: a systematic review of tumour biology and therapeutic targets","volume":"33","author":"Hassan","year":"2025","journal-title":"Oncol. Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218354_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jmcb\/mjy080","article-title":"SOX2 in cancer stemness: tumor malignancy and therapeutic potentials","volume":"12","author":"Mamun","year":"2020","journal-title":"J. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1634\/stemcells.2008-0493","article-title":"SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity","volume":"27","author":"Gangemi","year":"2009","journal-title":"Stem Cell."},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-021-00857-0","article-title":"Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications","volume":"7","author":"Lopez-Bertoni","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"11","key":"10.1016\/j.canlet.2026.218354_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026740","article-title":"Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas","volume":"6","author":"Alonso","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.canlet.2026.218354_bib18","first-page":"139","article-title":"SOX2 expression and amplification in gliomas and glioma cell lines","volume":"8","author":"Annovazzi","year":"2011","journal-title":"Cancer Genomics Proteomics"},{"issue":"2","key":"10.1016\/j.canlet.2026.218354_bib19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"issue":"46","key":"10.1016\/j.canlet.2026.218354_bib20","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1038\/s41388-025-03595-7","article-title":"Par6\/SOX2 interact to modulate stemness maintenance in glioma by regulating the EGFR\/PI3K\/AKT signaling Cascade","volume":"44","author":"Yang","year":"2025","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10555-023-10144-9","article-title":"Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked?","volume":"43","author":"Fatma","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.canlet.2026.218354_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","article-title":"Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells","volume":"157","author":"Suva","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.canlet.2026.218354_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nprot.2006.478","article-title":"Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts","volume":"2","author":"Frezza","year":"2007","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cmet.2018.08.002","article-title":"Mitochondrial DNA variation dictates expressivity and progression of nuclear DNA mutations causing cardiomyopathy","volume":"29","author":"McManus","year":"2019","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.canlet.2026.218354_bib25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-19-0909","article-title":"Genomic and phenotypic characterization of a broad Panel of patient-derived xenografts reflects the diversity of glioblastoma","volume":"26","author":"Vaubel","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.canlet.2026.218354_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133247","article-title":"Integrative cBioPortal analysis revealed molecular mechanisms that regulate EGFR-PI3K-AKT-mTOR pathway in diffuse gliomas of the brain","volume":"13","author":"Brlek","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218354_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fcell.2020.00200","article-title":"Mitophagy: an emerging role in aging and age-associated diseases","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218354_bib28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1089\/dna.2019.5013","article-title":"Biological and clinical relevance of microRNAs in mitochondrial diseases\/dysfunctions","volume":"39","author":"Sekar","year":"2020","journal-title":"DNA Cell Biol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218354_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12040895","article-title":"Reverse electron transport at mitochondrial complex I in ischemic stroke, aging, and age-related diseases","volume":"12","author":"Chavda","year":"2023","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.canlet.2026.218354_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cmet.2018.09.019","article-title":"Metformin targets mitochondrial electron transport to reduce air-pollution-induced thrombosis","volume":"29","author":"Soberanes","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218354_bib31","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fphys.2017.00428","article-title":"Role of mitochondrial reverse electron transport in ROS signaling: potential roles in health and disease","volume":"8","author":"Scialo","year":"2017","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218354_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/13543776.2018.1432596","article-title":"Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011-2016)","volume":"28","author":"Hameed","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"6","key":"10.1016\/j.canlet.2026.218354_bib33","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5646","article-title":"Quinazolinone derivatives as potential anti-tumor agents: structural features and molecular mechanisms in inducing cell death","volume":"56","author":"Li","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.canlet.2026.218354_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.devcel.2017.02.020","article-title":"The putative Drp1 inhibitor mdivi-1 is a reversible mitochondrial complex I inhibitor that modulates reactive oxygen species","volume":"40","author":"Bordt","year":"2017","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.canlet.2026.218354_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","article-title":"Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages","volume":"167","author":"Mills","year":"2016","journal-title":"Cell"},{"issue":"6282","key":"10.1016\/j.canlet.2026.218354_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.aad4017","article-title":"Complementation of mitochondrial electron transport chain by manipulation of the NAD+\/NADH ratio","volume":"352","author":"Titov","year":"2016","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.canlet.2026.218354_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218354_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.tcb.2023.02.004","article-title":"The autophagy-NAD axis in longevity and disease","volume":"33","author":"Wilson","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"7793","key":"10.1016\/j.canlet.2026.218354_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-Cancer Analysis of Whole Genomes Consortium, Pan-cancer analysis of whole genomes","volume":"578","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.canlet.2026.218354_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15092613","article-title":"The role of hypoxia and cancer stem cells in development of glioblastoma","volume":"15","author":"Shi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218354_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218216","article-title":"Tumor microenvironment in glioblastoma: the central role of the hypoxic-necrotic core","volume":"639","author":"Bayona","year":"2026","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2026.218354_bib42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ccr.2011.02.014","article-title":"SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization","volume":"19","author":"Finley","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.canlet.2026.218354_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-007-9400-9","article-title":"Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression","volume":"85","author":"Candolfi","year":"2007","journal-title":"J. Neuro Oncol."},{"issue":"14","key":"10.1016\/j.canlet.2026.218354_bib44","first-page":"3207","article-title":"Cancer stem cell markers in glioblastoma - an update","volume":"21","author":"Xu","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.canlet.2026.218354_bib45","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/1878-0261.13200","article-title":"NOX4 regulates TGFbeta-induced proliferation and self-renewal in glioblastoma stem cells","volume":"16","author":"Garcia-Gomez","year":"2022","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218354_bib46","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbrc.2013.12.097","article-title":"TGF-Beta promotes glioma cell growth via activating Nodal expression through Smad and ERK1\/2 pathways","volume":"443","author":"Sun","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.canlet.2026.218354_bib47","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tcb.2023.03.009","article-title":"Mitochondria in cancer stem cells: achilles heel or hard armor","volume":"33","author":"Zheng","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib48","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","article-title":"Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib49","first-page":"11","article-title":"Alterations in mitochondrial function and energy metabolism-related properties in thyroid cancer stem cells","volume":"69","author":"Ren","year":"2021","journal-title":"Acta Biochim. Pol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib50","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13287-019-1467-7","article-title":"Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma","volume":"10","author":"Yuan","year":"2019","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41467-025-67091-y","article-title":"Lactate mitochondrial oxidation drives stemness potential in metastatic breast cancer","volume":"17","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.canlet.2026.218354_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050545","article-title":"Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3","volume":"7","author":"Sol","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.canlet.2026.218354_bib53","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1021\/acs.jproteome.8b00260","article-title":"SIRT3 overexpression inhibits growth of kidney tumor cells and enhances mitochondrial biogenesis","volume":"17","author":"Liu","year":"2018","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218354_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tips.2023.12.005","article-title":"Context-dependent role of SIRT3 in cancer","volume":"45","author":"Zhang","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.canlet.2026.218354_bib55","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1002\/jcp.26474","article-title":"Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K\/Akt-MAPK pathway","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2026.218354_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116004","article-title":"SIRT3 regulates mitochondrial function: a promising star target for cardiovascular disease therapy","volume":"170","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.canlet.2026.218354_bib57","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3892\/or.2013.2604","article-title":"Sirt3 is a tumor suppressor in lung adenocarcinoma cells","volume":"30","author":"Xiao","year":"2013","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.canlet.2026.218354_bib58","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1158\/1535-7163.MCT-15-0675","article-title":"Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model","volume":"15","author":"Lee","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.canlet.2026.218354_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/jca.54402","article-title":"HIF1alpha\/HIF2alpha induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions","volume":"13","author":"Wang","year":"2022","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218354_bib60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bjc.6605551","article-title":"Hypoxia inducible factors in cancer stem cells","volume":"102","author":"Heddleston","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2026.218354_bib61","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrd1199","article-title":"HIF-1 as a target for drug development","volume":"2","author":"Giaccia","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.canlet.2026.218354_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16112089","article-title":"Understanding the significance of hypoxia-inducible factors (HIFs) in glioblastoma: a systematic review","volume":"16","author":"Begagic","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:10:33Z","timestamp":1777551033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"alternative-id":["S0304383526001175"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218354","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial reverse electron transport regulates glioma stemness through Sirt3-HIF1\u03b1-SOX2 signaling","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218354"}}